Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D Milovan Matovic"'
Calculation of absorbed dose due to the 90Y-DOTATOC peptide receptor radionuclide therapy by MCNP5/X
Autor:
Z Dragana Krstic, Z Marija Jeremic, D Milovan Matovic, R Dragoslav Nikezic, B Suzana Pantovic
Publikováno v:
Nuclear Technology and Radiation Protection, Vol 33, Iss 4, Pp 380-385 (2018)
Strong beta emitters, like 90Y, 177Lu labelled peptide, are used for treatment of neuroendocrine tumours where there is a good expression of somatostatin receptors. In this work, MCNP5/X computer software and ORNL human phantoms were used to calculat
Autor:
D Miroslav Ravlic, Z Marina Vlajkovic, M Slobodan Jankovic, Z Marija Jeremic, D Milovan Matovic
Publikováno v:
Nuclear Technology and Radiation Protection, Vol 33, Iss 2, Pp 223-229 (2018)
After receiving high doses of radioiodine the patients have to remain isolated within the “restricted area”, until the radioactivity of the body drops below a certain level. The aim of this paper was to present our alarming system designed to dis
Autor:
Z Marija Jeremic, D Vera Spasojevic-Tisma, T Snezana Zivancevic-Simonovic, Ivan Pavlovic Lj., U Ana Todorovic, A Snezana Pejic, N Vera Todorovic, D Milovan Matovic, B Olgica Mihaljevic, Vladimir Jakovljevic Lj.
Publikováno v:
Nuclear technology and radiation protection
Nuclear Technology and Radiation Protection, Vol 32, Iss 4, Pp 358-365 (2017)
Nuclear Technology and Radiation Protection, Vol 32, Iss 4, Pp 358-365 (2017)
The radioactive iodine (131I) ablation is a well-accepted treatment modality for differentiated thyroid cancer patients. Unfortunately, the radiation induces the oxidative stress and damages cells and tissues, simultaneously activating the mechanisms